Published in BMJ on October 10, 1998
A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry (2001) 1.53
A model for intervention research in late-life depression. Int J Geriatr Psychiatry (2009) 0.95
White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur Arch Psychiatry Clin Neurosci (2007) 0.95
Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial. Psychosom Med (2013) 0.94
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry (2003) 0.93
Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review. Int Rev Psychiatry (2009) 0.92
Blood pressure and white matter integrity in geriatric depression. J Affect Disord (2008) 0.91
Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women. Int J Geriatr Psychiatry (2012) 0.89
Structural neuroimaging research methods in geriatric depression. Am J Geriatr Psychiatry (2006) 0.88
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. Int J Clin Pract (2007) 0.88
Structural neuroimaging of geriatric depression. Psychiatr Clin North Am (2011) 0.87
Biological basis of late life depression. Curr Psychiatry Rep (2012) 0.85
A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Aust N Z J Psychiatry (2011) 0.84
White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia. Dement Geriatr Cogn Dis Extra (2012) 0.84
Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialogues Clin Neurosci (2007) 0.81
White Matter Hyperintensity Accumulation During Treatment of Late-Life Depression. Neuropsychopharmacology (2015) 0.80
Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience. Int J Geriatr Psychiatry (2008) 0.80
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials. Am J Psychiatry (2016) 0.80
Reductions in neuronal density in elderly depressed are region specific. Int J Geriatr Psychiatry (2009) 0.79
Severe deep white matter lesions and outcome in major depressive disorder. Further investigation of deep white matter lesions is necessary. BMJ (1999) 0.75
Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation. Behav Neurol (2017) 0.75
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry (1986) 6.14
Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology (1993) 5.72
A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry (1996) 2.75
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol (1992) 1.29
1997 IPA/Bayer Research Awards in Psychogeriatrics. Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment. Int Psychogeriatr (1997) 1.15
Computed tomography and the outcome of affective disorder: a follow-up study of elderly patients. Br J Psychiatry (1981) 0.97
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31
Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J (1990) 5.08
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65
A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry (1996) 2.75
Drugs used for psychiatric disorders. Med J Aust (1993) 2.51
Refining the perfusion-diffusion mismatch hypothesis. Stroke (2005) 2.44
The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Respir J (2005) 2.37
Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry (1999) 2.14
Behavioral and psychological symptoms of dementia in developing countries. Int Psychogeriatr (2004) 2.03
Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology (2010) 1.99
Is diazepam an antidepressant? Br J Psychiatry (1989) 1.96
Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry (2001) 1.69
A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med (1998) 1.58
White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology (2010) 1.55
Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol (1995) 1.49
Tacrine in Alzheimer's disease. Lancet (1989) 1.41
Pharmacological treatment of cognitive deficits in Alzheimer's disease. Med J Aust (2001) 1.40
Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry (1997) 1.39
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology (2011) 1.37
The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem (1990) 1.36
Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg (1999) 1.36
Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med (1997) 1.34
Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Mol Psychiatry (2008) 1.32
Causes of death in Huntington's disease. Med J Aust (1982) 1.30
Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry (1992) 1.29
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology (2012) 1.27
Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J (1996) 1.27
Neuropsychological and structural brain changes in anorexia nervosa before and after refeeding. Psychol Med (1996) 1.27
Mephenytoin hydroxylation deficiency: kinetics after repeated doses. Clin Pharmacol Ther (1984) 1.25
Preoperative prediction of pulmonary complications following thoracic surgery. Chest (1993) 1.24
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B. Hepatology (2000) 1.23
Semantic priming in thought disordered schizophrenic patients. Schizophr Res (1991) 1.23
Do blood transfusions improve outcomes related to mechanical ventilation? Chest (2001) 1.19
Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry (2013) 1.19
The provision of public health nursing follow-up services for postnatal clients in Ontario: a cross-sectional survey. Can J Public Health (1992) 1.19
Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol (1995) 1.18
Huntington's disease: the establishment of a national register. Med J Aust (1978) 1.13
A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res (2001) 1.12
Removal of impacted endoscopic basket and stone from the common bile duct by extracorporeal shock waves. Endoscopy (1990) 1.12
Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. Int Psychogeriatr (2013) 1.10
Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J Viral Hepat (2001) 1.10
Do memory clinics improve the quality of life of carers? A randomized pilot trial. Int J Geriatr Psychiatry (1999) 1.09
Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol (1995) 1.08
Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Transl Psychiatry (2012) 1.07
Risk factors for recurrent emergency department visits for asthma. Thorax (1995) 1.05
The Simon effect and attention deficits in Gilles de la Tourette's syndrome and Huntington's disease. Brain (1995) 1.05
Risk factors for development of flucloxacillin associated jaundice. BMJ (1993) 1.04
Characterization of the innate immune signalling pathways in hepatocyte cell lines. J Viral Hepat (2008) 1.03
Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br J Psychiatry (1996) 1.02
Perfusion thresholds in acute stroke thrombolysis. Stroke (2003) 1.02
Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther (2004) 1.01
Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits. Seizure (1997) 1.00
Surgical treatment of carcinoma of the male urethra. Urol Clin North Am (1992) 1.00
Mandibular invasion by squamous cell carcinoma: a computed tomographic and histological study. Br J Oral Maxillofac Surg (1996) 0.99
White matter lesions in depression and Alzheimer's disease. Br J Psychiatry (1996) 0.98
Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology (1997) 0.98
Asthma management preceding an emergency department visit. Arch Intern Med (1992) 0.98
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Mol Psychiatry (2012) 0.98
The predictive value of dementia screening instruments in clinical populations. Int J Geriatr Psychiatry (1997) 0.98
Cross-national interrater reliability of dementia diagnosis in the elderly and factors associated with disagreement. Neurology (1996) 0.97
Characteristics of handwriting of patients with Huntington's disease. Mov Disord (1994) 0.97
Magnetic resonance imaging of trabecular bone structure in the distal radius: relationship with X-ray tomographic microscopy and biomechanics. Osteoporos Int (1996) 0.97
Incidental radiological findings on brain magnetic resonance imaging in first-episode psychosis and chronic schizophrenia. Acta Psychiatr Scand (2002) 0.96
Violence in schizophrenia: role of hallucinations and delusions. Schizophr Res (1997) 0.96
Geriatric psychiatry in Australia. Int J Geriatr Psychiatry (1997) 0.96
Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence. Evid Based Complement Alternat Med (2012) 0.95
Fluoxetine, akathisia, and suicidality: is there a causal connection? Arch Gen Psychiatry (1992) 0.95
Evaluation of technical factors affecting the quantification of trabecular bone structure using magnetic resonance imaging. Bone (1995) 0.94
Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis. Ann Neurol (2000) 0.94
Motor overflow in Huntington's disease. J Neurol Neurosurg Psychiatry (2004) 0.94
Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link? JAMA (1993) 0.94
The ordered logistic regression model in psychiatry: rising prevalence of dementia in old people's homes. Stat Med (1989) 0.94
Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol (2012) 0.93
Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review. Aust N Z J Psychiatry (1999) 0.93
Impaired movement sequencing in patients with Huntington's disease: a kinematic analysis. Neuropsychologia (1995) 0.93
Gait dysfunction in Huntington's disease: parkinsonism and a disorder of timing. Implications for movement rehabilitation. Adv Neurol (2001) 0.93
Reliance on advance information and movement sequencing in Huntington's disease. Mov Disord (1995) 0.92
A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness. J Affect Disord (1985) 0.92
Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection. Ther Drug Monit (1997) 0.91
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. Antimicrob Agents Chemother (1990) 0.90
Failure of an alkalophilic bacterium to synthesize ATP in response to a valinomycin-induced potassium diffusion potential at high pH. Arch Biochem Biophys (1985) 0.89
An examination of pain perception and cerebral event-related potentials following carbon dioxide laser stimulation in patients with Alzheimer's disease and age-matched control volunteers. Pain Res Manag (2001) 0.89
The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol Med (1994) 0.89
Nasal lymphoma. A retrospective analysis of 60 cases. Cancer (1990) 0.87
Integrated care improves risk-factor modification after stroke: initial results of the Integrated Care for the Reduction of Secondary Stroke model. J Neurol Neurosurg Psychiatry (2008) 0.87
Computed tomographic study of children with classic autism. Arch Neurol (1984) 0.87
Intense physical activity is associated with cognitive performance in the elderly. Transl Psychiatry (2012) 0.86
Hypertrophic cardiomyopathy in systemic lupus erythematosus and "lupus-like" disease. Chance association? A report of 2 cases. J Rheumatol (1992) 0.86